• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	118,600	02.07.24 08:03:41	-0,800	-0,67%	118,600	119,000	118,600	119,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	78,500	02.07.24 08:20:56	+0,500	+0,64%	78,500	79,500	78,500	78,000